Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT)
Published in
Multiple Sclerosis Journal – Experimental, Translational and Clinical, August 2026
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2026.
All research outputs
#4,538,931
of 34,394,870 outputs
Outputs from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#94
of 531 outputs
Outputs of similar age
#30,372
of 331,907 outputs
Outputs of similar age from Multiple Sclerosis Journal – Experimental, Translational and Clinical
#1
of 19 outputs
Altmetric has tracked 34,394,870 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 531 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,907 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.
